Skip to content

Drug interactions

Palbociclib + Ribociclib

Severity: Major

Palbociclib and Ribociclib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both are CDK4/6 inhibitors with overlapping myelosuppression, and ribociclib may modestly raise palbociclib exposure through CYP3A4 inhibition. The combination is not an established regimen and adds toxicity without proven benefit.

What this interaction means in plain words

Palbociclib and Ribociclib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Palbociclib belongs to Oncology; Ribociclib belongs to Oncology.

Evidence level: Low

Why it happens

Duplicate CDK4/6 inhibition with additive neutropenia plus CYP3A4 inhibition by ribociclib.

What to do

Avoid concurrent use of the two CDK4/6 inhibitors. If a switch is made, follow each drug's labeling and monitor blood counts.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Palbociclib and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Palbociclib with Ribociclib?

MediHelp rates the interaction as major. Palbociclib and Ribociclib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both are CDK4/6 inhibitors with overlapping myelosuppression, and ribociclib may modestly raise palbociclib exposure through CYP3A4 inhibition. The combination is not an established regimen and adds toxicity without proven benefit.

How serious is the interaction between Palbociclib and Ribociclib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use of the two CDK4/6 inhibitors. If a switch is made, follow each drug's labeling and monitor blood counts.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in